bluebird bio’s beta-thalassaemia gene therapy rejected by NICE
NICE determined that there were uncertainties around the cost-effectiveness of the therapy
Read More
Tag: beta-thalassaemia
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
